Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement

Karl A. Soderlund, Raghu R. Chivukula, Stuart D. Russell, John V. Conte, James Mudd, Marc K. Halushka

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: With the increasing use of left ventricular assist devices, the left ventricular apical core has become a more frequently encountered surgical pathology tissue. We investigated the prognostic value of this cardiac tissue in short-term patient mortality. Previous studies have shown that the degree of cardiac fibrosis correlates with improvements in ejection fraction and the likelihood of weaning from an assist device. Methods: Left ventricular apical core tissues from 29 sequential subjects who received a HeartMate II continuous axial flow left ventricular assist device were studied retrospectively to determine whether interstitial fibrosis, replacement fibrosis (scar), the presence of mural thrombus, or other histopathologic findings were associated with hemodynamic changes or mortality in this population. Patients received left ventricular assist devices as bridges to transplantation or as destination therapy. Interstitial fibrosis was determined by observer scoring and digital scoring methods. Before and after left ventricular assist device procedure, right heart catheterizations were reviewed for clinical cardiac data. Results: The presence of replacement fibrosis in the apical core tissue significantly correlated with decreased improvement in pulmonary capillary wedge pressure after left ventricular assist device placement (P=.02). Ten subjects died over the course of this study. No specimen variables, including scar, interstitial fibrosis, and the presence of mural thrombosis, correlated with patient mortality. Conclusions: Pathologic findings in left ventricular apical cores have little prognostic utility in guiding patient management as related to overall 1-year mortality, but may indicate patients who are more likely to positively remodel their hearts.

Original languageEnglish (US)
Pages (from-to)217-222
Number of pages6
JournalCardiovascular Pathology
Volume18
Issue number4
DOIs
StatePublished - Jul 2009
Externally publishedYes

Fingerprint

Heart-Assist Devices
Fibrosis
Mortality
Cicatrix
Thrombosis
Surgical Pathology
Pulmonary Wedge Pressure
Cardiac Catheterization
Weaning
Research Design
Transplantation
Hemodynamics
Equipment and Supplies
Population

Keywords

  • Fibrosis
  • HeartMate II
  • Left ventricle
  • Myocardium

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Pathology and Forensic Medicine

Cite this

Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement. / Soderlund, Karl A.; Chivukula, Raghu R.; Russell, Stuart D.; Conte, John V.; Mudd, James; Halushka, Marc K.

In: Cardiovascular Pathology, Vol. 18, No. 4, 07.2009, p. 217-222.

Research output: Contribution to journalArticle

Soderlund, Karl A. ; Chivukula, Raghu R. ; Russell, Stuart D. ; Conte, John V. ; Mudd, James ; Halushka, Marc K. / Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement. In: Cardiovascular Pathology. 2009 ; Vol. 18, No. 4. pp. 217-222.
@article{abf212417b714222966317d067a16940,
title = "Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement",
abstract = "Background: With the increasing use of left ventricular assist devices, the left ventricular apical core has become a more frequently encountered surgical pathology tissue. We investigated the prognostic value of this cardiac tissue in short-term patient mortality. Previous studies have shown that the degree of cardiac fibrosis correlates with improvements in ejection fraction and the likelihood of weaning from an assist device. Methods: Left ventricular apical core tissues from 29 sequential subjects who received a HeartMate II continuous axial flow left ventricular assist device were studied retrospectively to determine whether interstitial fibrosis, replacement fibrosis (scar), the presence of mural thrombus, or other histopathologic findings were associated with hemodynamic changes or mortality in this population. Patients received left ventricular assist devices as bridges to transplantation or as destination therapy. Interstitial fibrosis was determined by observer scoring and digital scoring methods. Before and after left ventricular assist device procedure, right heart catheterizations were reviewed for clinical cardiac data. Results: The presence of replacement fibrosis in the apical core tissue significantly correlated with decreased improvement in pulmonary capillary wedge pressure after left ventricular assist device placement (P=.02). Ten subjects died over the course of this study. No specimen variables, including scar, interstitial fibrosis, and the presence of mural thrombosis, correlated with patient mortality. Conclusions: Pathologic findings in left ventricular apical cores have little prognostic utility in guiding patient management as related to overall 1-year mortality, but may indicate patients who are more likely to positively remodel their hearts.",
keywords = "Fibrosis, HeartMate II, Left ventricle, Myocardium",
author = "Soderlund, {Karl A.} and Chivukula, {Raghu R.} and Russell, {Stuart D.} and Conte, {John V.} and James Mudd and Halushka, {Marc K.}",
year = "2009",
month = "7",
doi = "10.1016/j.carpath.2008.06.007",
language = "English (US)",
volume = "18",
pages = "217--222",
journal = "Cardiovascular Pathology",
issn = "1054-8807",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement

AU - Soderlund, Karl A.

AU - Chivukula, Raghu R.

AU - Russell, Stuart D.

AU - Conte, John V.

AU - Mudd, James

AU - Halushka, Marc K.

PY - 2009/7

Y1 - 2009/7

N2 - Background: With the increasing use of left ventricular assist devices, the left ventricular apical core has become a more frequently encountered surgical pathology tissue. We investigated the prognostic value of this cardiac tissue in short-term patient mortality. Previous studies have shown that the degree of cardiac fibrosis correlates with improvements in ejection fraction and the likelihood of weaning from an assist device. Methods: Left ventricular apical core tissues from 29 sequential subjects who received a HeartMate II continuous axial flow left ventricular assist device were studied retrospectively to determine whether interstitial fibrosis, replacement fibrosis (scar), the presence of mural thrombus, or other histopathologic findings were associated with hemodynamic changes or mortality in this population. Patients received left ventricular assist devices as bridges to transplantation or as destination therapy. Interstitial fibrosis was determined by observer scoring and digital scoring methods. Before and after left ventricular assist device procedure, right heart catheterizations were reviewed for clinical cardiac data. Results: The presence of replacement fibrosis in the apical core tissue significantly correlated with decreased improvement in pulmonary capillary wedge pressure after left ventricular assist device placement (P=.02). Ten subjects died over the course of this study. No specimen variables, including scar, interstitial fibrosis, and the presence of mural thrombosis, correlated with patient mortality. Conclusions: Pathologic findings in left ventricular apical cores have little prognostic utility in guiding patient management as related to overall 1-year mortality, but may indicate patients who are more likely to positively remodel their hearts.

AB - Background: With the increasing use of left ventricular assist devices, the left ventricular apical core has become a more frequently encountered surgical pathology tissue. We investigated the prognostic value of this cardiac tissue in short-term patient mortality. Previous studies have shown that the degree of cardiac fibrosis correlates with improvements in ejection fraction and the likelihood of weaning from an assist device. Methods: Left ventricular apical core tissues from 29 sequential subjects who received a HeartMate II continuous axial flow left ventricular assist device were studied retrospectively to determine whether interstitial fibrosis, replacement fibrosis (scar), the presence of mural thrombus, or other histopathologic findings were associated with hemodynamic changes or mortality in this population. Patients received left ventricular assist devices as bridges to transplantation or as destination therapy. Interstitial fibrosis was determined by observer scoring and digital scoring methods. Before and after left ventricular assist device procedure, right heart catheterizations were reviewed for clinical cardiac data. Results: The presence of replacement fibrosis in the apical core tissue significantly correlated with decreased improvement in pulmonary capillary wedge pressure after left ventricular assist device placement (P=.02). Ten subjects died over the course of this study. No specimen variables, including scar, interstitial fibrosis, and the presence of mural thrombosis, correlated with patient mortality. Conclusions: Pathologic findings in left ventricular apical cores have little prognostic utility in guiding patient management as related to overall 1-year mortality, but may indicate patients who are more likely to positively remodel their hearts.

KW - Fibrosis

KW - HeartMate II

KW - Left ventricle

KW - Myocardium

UR - http://www.scopus.com/inward/record.url?scp=67649402016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649402016&partnerID=8YFLogxK

U2 - 10.1016/j.carpath.2008.06.007

DO - 10.1016/j.carpath.2008.06.007

M3 - Article

C2 - 18706833

AN - SCOPUS:67649402016

VL - 18

SP - 217

EP - 222

JO - Cardiovascular Pathology

JF - Cardiovascular Pathology

SN - 1054-8807

IS - 4

ER -